We only have this paper's title and publication details.
Read it at the sourceAnswers are grounded in this paper and cite their sources.
High prices put promising monoclonal antibodies out of reach for many patients
No takes yet. Share an insight, caveat, or question.
Burch et al. (2018) studied this question.
Synapse has enriched 10 related papers. Consider them for comparative context: